The profile is currenly unclaimed by the seller. All information is provided by CB Insights.

gldrugdev.com

Stage

Acquired | Acquired

About Great Lakes Drug Development

Great Lakes Drug Development provides strategic, operational and interim management support for early drug development projects. The company's services include clinical pharmacology development support; pharmacokinetic, pharmacodynamic and biostatistical analysis and reporting; program / project management; and pharmacometric modeling and simulation techniques to guide early and informed decision making.

Great Lakes Drug Development Headquarter Location

123 Brighton Lake Road

Brighton, Michigan, 48116,

United States

810-224-7506

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Latest Great Lakes Drug Development News

Certara Announces Acquisition of Great Lakes Drug Development, Inc.

Aug 14, 2013

Acquisition will further increase the depth of Certara’s early drug development analysis, modeling and simulation expertise August 13, 2013 08:00 AM Eastern Daylight Time ST. LOUIS--( BUSINESS WIRE )--Certara™, a leading provider of software and scientific consulting services to improve productivity and decision-making from drug discovery through drug development, today announced that it has acquired drug development consultancy firm Great Lakes Drug Development, Inc. (“GLDD”), based in Brighton, MI. Both companies possess considerable expertise in pharmacokinetic (PK) and pharmacodynamic (PD) analysis, project management, and pharmacometric modeling and simulation. GLDD focuses on early development work, while Certara’s products and services span the entire drug development continuum. Financial details about the transaction have not been disclosed. “This acquisition will enable us to leverage the significant synergies between Certara’s and GLDD’s business focus, experience, and culture, while expanding our customer base,” said Daniel Weiner, Ph.D., senior vice president and general manager at Certara. The addition of GLDD builds on the capabilities Tripos®, Pharsight® and Simcyp™ bring to Certara. GLDD’s Chief Executive Officer, David Hermann, said, “This is an exciting stage in our company’s evolution. We look forward to joining Certara’s Pharsight Consulting Services to enhance their capabilities and provide our customers with access to additional services and expertise.” The GLDD office in Brighton, MI will become the sixth in Certara’s worldwide consultancy operations including 75 Ph.D. staff in Sunnyvale, CA; Cary, NC; Montreal, Canada; Tokyo, Japan; and Sheffield, England. About Certara Certara is dedicated to improving human health by delivering a broad spectrum of software products and consulting services, spanning molecular discovery to clinical development, with special focus on supporting translational approaches to drug development. A leading provider of model-based drug development tools, Certara was formed by the acquisition and integration of industry leaders Tripos®, Simcyp™, and Pharsight® Corporation. Each Certara family brand focuses on a key phase within the drug discovery and development process; combined, they offer a unique set of scientific modeling, analysis, and simulation capabilities that can enable the cross-disciplinary approaches necessary for translational science initiatives. For more information, visit www.certara.com . About Great Lakes Drug Development, Inc. Great Lakes Drug Development provides strategic, operational and interim management support for early drug development projects. The company’s services include clinical pharmacology development support; pharmacokinetic, pharmacodynamic and biostatistical analysis and reporting; program / project management; and pharmacometric modeling and simulation techniques to guide early and informed decision making. Contacts

  • Where is Great Lakes Drug Development's headquarters?

    Great Lakes Drug Development's headquarters is located at 123 Brighton Lake Road, Brighton.

  • What is Great Lakes Drug Development's latest funding round?

    Great Lakes Drug Development's latest funding round is Acquired.

  • Who are the investors of Great Lakes Drug Development?

    Investors of Great Lakes Drug Development include Certara.

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.